Lucira Health Inc
LHDX.O- Latest Trade
- trading lower2.84USD
- Change
- -0.5
- % Change
14.87%Negative
- As of Aug 16 2022. Values delayed up to 15 minutes
- Day Range
- 2.56 - 3.00
- 52-Week Range
- 1.36 - 10.65
- Previous Close
- 3.34
- Open
- 3.00
- Volume
- 85,765.00
- 3 Month Average Trading Volume
- 1.40
- Shares Out (Mil)
- 39.83
- Market Cap
- 133.16
- Forward P/E
- 9.54
- Dividend Yield
- -99,999.99
Key Statistics
3 mean rating - 3 analysts
- P/E Excl. Extra Items (TTM)
- -99,999.99
- Price To Sales (TTM)
- 0.74
- Price To Book (Quarterly)
- 0.65
- Price To Cash Flow (Per Share TTM)
- -99,999.99
- Total Debt/Total Equity (Quarterly)
- 14.18
- Long Term Debt/Equity (Quarterly)
- 14.18
- Return On Investment (TTM)
- -16.51
- Return On Equity (TTM)
- -13.89
2021 (millions USD)
About Lucira Health Inc (LHDX.O)
Company Information
Lucira Health, Inc. is medical technology company. The Company is focused on the development and commercialization of transformative and infectious disease test kits. The Company has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and test kit that is powered by two AA batteries and fit in the palm of a hand. Its initial focus is within respiratory diseases, starting with COVID-19 and influenza A and B virus indications. It has developed LUCIRA COVID-19 All-In-One Test Kit (COVID-19 test kit), is a single-use, molecular in vitro diagnostic test that has an analytical sensitivity to detect the SARS-CoV-2 virus. The test is authorized for prescription at-home use.
Address
1412 62nd StreetEMERYVILLE, CA
94608
United States
Industry
Biotechnology & Drugs
Executive Leadership
- Erik T. Engelson
- President, Chief Executive Officer, Director
- Daniel George
- Chief Financial Officer, Treasurer
- Hansgregory Charles Hartmann
- Chief Operating Officer
- Ghazi Kashmolah
- Chief Quality Officer and Executive Vice President Regulatory Affairs
- Kelly Lewis Brezoczky
- Executive Vice President - Commercialization, Regulatory, Clinical and Business Development
- Debkishore Mitra
- Chief Technology Officer
- Tamanna Prashar
- Vice President - Global Supply Chain, Operations and Quality
- Sandra A. Gardiner
- Independent Director
- David A. Lamond
- Independent Director
- Erica J. Rogers
- Independent Director
- Lior Susan
- Independent Director
- Steve Tablak
- Independent Director
- Tuff Yen
- Independent Director
Latest News
- MarketsCarnival Corp, Insignia Systems, Scienjoy
The Dow inched towards an all-time high on Wednesday, on a boost from retailers Home Depot and Nike, while record daily U.S. COVID-19 infections kept gains in check amid low trading volumes in the final week of the year.
- MarketsCalix, Codex DNA, Victoria's Secret
The Dow inched towards an all-time high on Wednesday, on a boost from retailers Home Depot and Nike, while record daily U.S. COVID-19 infections kept gains in check amid low liquidity in the final week of the year.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,773.90 | 0.42%Negative |
| Copper | 666.45 | 1.42%Negative |
| Brent Crude Oil | 92.44 | 2.80%Negative |
| CBOT Soybeans | 1,453.25 | 2.73%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,316.74 | 0.46%Positive |
| Euro STOXX 50 | 3,805.22 | 0.41%Positive |
| FTSE 100 | 7,536.06 | 0.36%Positive |
| Nikkei 225 | 28,868.91 | 0.01%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes